Sign in

Gilbert A. Fuller

About Gilbert A. Fuller

Gilbert A. Fuller (age 84) is an independent director of Security National Financial Corporation (SNFCA), serving on the Board since 2012. He is a former Executive Vice President, Chief Financial Officer, and Secretary of USANA Health Sciences, Inc. (2006–2008), and has served on USANA’s Board since 2008. He holds a B.S. in Accounting and an M.B.A. from the University of Utah. The Board has designated him an “audit committee financial expert” under Item 407(d) of Regulation S-K, reflecting deep accounting and finance credentials .

Past Roles

OrganizationRoleTenureCommittees/Impact
USANA Health Sciences, Inc.Executive Vice President, Chief Financial Officer, and Secretary2006–2008Senior finance leadership at a NYSE-listed multinational; drove finance, accounting, and corporate strategy
USANA Health Sciences, Inc.Senior Vice President1999–2006Promoted from VP Finance; expanded corporate finance responsibilities
USANA Health Sciences, Inc.Vice President of Finance1996–1999Led finance function during growth; pre-CFO track

External Roles

OrganizationRolePublic/PrivateStart YearNotes
USANA Health Sciences, Inc.DirectorPublic (NYSE)2008No SNFCA related-party transactions disclosed with USANA; reduces conflict risk

Board Governance

  • Independence: The Board affirmatively determined Fuller is independent under Nasdaq listing standards .
  • Committee assignments (2024 activity levels in parentheses):
    • Audit Committee — Chair; designated Audit Committee financial expert; met 3x in 2024 .
    • Compensation Committee — Member; all independent directors; met 3x in 2024 .
    • Nominating & Corporate Governance Committee — Member; all independent directors; met 2x in 2024 .
    • Executive Committee — Member; met 1x in 2024 .
  • Attendance: Board met 5 times in 2024; all directors attended all meetings except one absence by another director, implying 100% attendance by Fuller .
  • Leadership structure: CEO also serves as Chair; no standing lead independent director, though independent directors meet in executive session and H. Craig Moody is designated to preside at those sessions .

Fixed Compensation

Director cash compensation and equity by year (outside director):

Metric20232024
Fees Earned or Paid in Cash ($)$38,250 $45,450
Stock Awards ($)$3,567 $8,165
Option Awards ($)$0 $0
Total ($)$41,817 $53,615
  • Program terms: Outside Directors receive $43,200 annual retainer plus $750 per day for certain management and Audit Committee meetings; annual equity choice of 1,000 options or 241 RSUs, and in 2024 an additional grant of 9,400 options or 2,268 RSUs at the director’s election; retirement benefit equals one month of director’s fees per year of service .

Performance Compensation

  • Director equity program is time-based (not performance-based). Options vest 25% per quarter over one year; RSU vesting for directors may be under one year following a 2023 plan amendment (shorter vesting can weaken long-term alignment) .
  • Fuller’s outstanding director equity:
Equity MetricAs of 2023As of 2024/2025
Options to purchase Class A common stock (outstanding)39,090 options 41,045 options
Restricted Stock Units (outstanding)2,245 RSUs 2,969 RSUs
Option vesting schedule25% quarterly over 1 year 25% quarterly over 1 year
RSU vesting policy for directorsAllowed vesting < 1 year (amendment in 2023) Allowed vesting < 1 year (amendment in 2023)

Other Directorships & Interlocks

CompanySectorRolePotential Interlock/Conflict
USANA Health Sciences, Inc.Nutritional supplementsDirectorNo related-party transactions between SNFCA and USANA disclosed; low direct conflict with SNFCA’s insurance, mortgage, and memorial services businesses

Expertise & Qualifications

  • Former public-company CFO and corporate secretary; decades of finance, accounting, and corporate strategy experience .
  • Audit Committee Chair and “financial expert,” indicating depth in internal controls, audit oversight, and financial reporting .
  • Advanced education in accounting and business (B.S. Accounting; M.B.A.) .

Equity Ownership

Metric20242025
Class A Shares Beneficially Owned53,691 (<1%) 40,601 (<1%)
Options Outstanding (Class A equivalent)39,090 41,045
RSUs Outstanding2,245 2,969
  • No pledge footnotes are disclosed for Fuller in the beneficial ownership tables (pledging would be a red flag if present) .

Insider Trading and Section 16(a) Notes

YearEvent/ObservationDetail
2023Late Section 16 filingsOne late filing upon vesting and sale of RSU shares; one upon exercise of an option (administrative timeliness issue; amounts/dates not provided)
2024Section 16(a) compliance summaryCompany’s review did not list Fuller among late filers for 2024 (others were cited)

Governance Assessment

  • Strengths

    • Independent director with strong financial acumen; Audit Committee Chair and SEC-defined financial expert; signed Audit Committee Report; supports robust financial reporting oversight .
    • Full board attendance in 2024; high engagement metrics across committees with multiple meetings held (Audit 3x; Comp 3x; Nominating 2x; Executive 1x) .
    • Committees (Compensation and Nominating) are fully independent; aligns with governance best practices .
    • Say-on-pay support was very strong in 2023 (approx. 98.6% approval), reflecting investor comfort with compensation oversight (Fuller serves on the Compensation Committee) .
  • Watch items / potential red flags

    • Combined CEO/Chair structure persists; no standing lead independent director (though an independent director presides over executive sessions). This structure centralizes authority and may reduce independent counterbalance on sensitive matters .
    • Family relationships among executives and directors (Quist family and a relative) represent a structural independence risk; oversight by independent directors like Fuller is critical in mitigating perceived conflicts .
    • Director RSUs permitted to vest in under one year after 2023 amendment; shorter vesting can diminish long-term alignment compared to multi-year vesting (particularly for directors) .
    • Proposed expansion of the 2022 Equity Incentive Plan by 3,000,000 shares implies up to 12.71% dilution on a fully converted basis; Compensation Committee and Board (including Fuller) supported the proposal—investors may scrutinize equity overhang and burn rate trends .
  • Related-party exposure

    • No related-person transactions disclosed involving Fuller; Audit Committee (which he chairs) reviews and approves related-party transactions; 2024 disclosures focus on transactions involving Quist family members serving as executives .
  • Compensation committee process

    • Compensation Committee composed solely of independent directors (including Fuller); for the 2024 equity plan amendment, neither the Board nor the Compensation Committee retained an outside consultant—investors may prefer independent advisor input on potentially dilutive equity authorizations .

Overall: Fuller enhances board effectiveness as an independent financial expert and Audit Chair with strong attendance and broad finance experience. Key governance risks relate to combined CEO/Chair structure, family interlocks among management/directors, shorter director RSU vesting, and equity plan dilution; continued strong committee oversight and transparent communication are important mitigants .